Briones-Garduño JC, Herrera-Villalobos JE, Vázquez-de Anda GF, Rodríguez-Roldán M, Pardo-Morales RV, González-Vargas A

Language: Spanish
References: 20
Page: 455-459
PDF size: 56.92 Kb.

ABSTRACT

Objective: To determine the relationship between erythrocyte deformations and preeclampsia-eclampsia syndrome before presentation of the triad high blood pressure-edema-proteinuria. Material and methods: Aleatory study. A total of 308 patients were studied without evidence of preeclampsia, with negative erythrocyte deformation smear, between 12 and 18 weeks of pregnancy. Monthly laboratory samples were performed including arterial blood pressure monitorization, weight, and periphery blood smear considered as positive with presence of 50% of morphologic changes of erythrocyte (equinocyte) deem in 10 fields, with light microscopic and oil immersion at 100X. Statistical studies were performed to determine relative risk (RR), sensitivity (S), and specificity (E), and positive and negative predictive values. Results: A total of 308 patients were studied; 36 patients (100%) had a positive smear, nine (25%) had preeclampsia. Erythrocyte deformation was seen at between 22 and 26 weeks of pregnancy in all patients before onset of high blood pressure, edema, and proteinuria; of 27 patients with positive smear who did not present preeclampsia (75%), five had thrombocytopenia, of five had edema and increased weight, and 17 were normal with normal vaginal delivery. A total of 267 patients who had negative smear until the end of pregnancy (98%), five (2%) had preeclampsia (sensitivity = 64%, specificity = 90%, VP+ = 25%, VP- = 98%, RR = 13.6%). Conclusions: There is a close relationship between erythrocyte deformations with onset of preeclampsia-eclampsia syndrome prior to presentation of the triad high blood pressure-edema-proteinuria.

REFERENCES

1. Briones GJC, Díaz-de León PM, Gómez-Bravo TE, Ávila EF, Briones VCG, Urrutia TF. Protocolo de manejo en la preeclampsia-eclampsia. Estudio comparativo. Cir Ciruj 1999;67:4-10.

2. Bravo-Topete GE, Briones GC, y cols. Frotis de sangre periférica y alteración orgánica en la preeclampsia-eclampsia. Cir Ciruj 2000; 68(4).

3. Cunningham FG, Lowe T, Guss, Mason R. Erythrocyte morphology in women with severe preeclampsia and eclampsia. Am J Obstet Gynecol 1985;153:358-363.

4. Sanchez-Ramos L, Adair CD, Todd JC, et al. Erythrocyte membrane fluidity in patients with preeclampsia and the HELLP syndrome: a preliminary study. J Matern Fetal Invest 1994;4:237-239.

5. Roberts JM, Hubel CA. Oxidative stresses the link in the two-stage model of preeclampsia. Lancet 1999;354:788-789.

6. Grisaru D, Zwang E, Peyser R, et al. The procoagulant activity of red blood cells from patients with severe preeclampsia. Am J Obstet Gynecol 1997;177:1513-1516.

7. Kenneth GP, Perry. Alteraciones de los eritrocitos. Tratamiento de las complicaciones clínicas del embarazo. In: Gleicher N, editor. Editorial Médica Panamericana. 3a. Ed. 2000;1354.

8. Díaz-de León PM, Espinosa MML, Briones GJC, López-Llera MM, Briones VCG. Microangiopatía trombótica y hemólisis intravascular en la preeclampsia-eclampsia. Los eslabones perdidos en el síndrome de HELLP. Rev Asoc Mex Med Crit Ter Int 1997;11:4-8.

9. Gómez-Bravo TE, Briones GJC, Díaz-de León PM, López-Llera MM, Ayala RA, Morales EJG, Ávila EF, Ramírez LB, Briones VCG. Microangiopatía trombótica y hemolítica intravascular en la preeclampsia severa. Presentación de un caso. Rev Asoc Med Crit Ter Int 2002; 16(1):29-32.

10. Briones GJC, Rodríguez RM, Herrera VJE, González VA, Morales PRV. Asociación de equinocitos en el frotis de sangre periférica con el síndrome de preeclampsia-eclampsia. Trabajo de grado Maestría en Investigación Clínica, UAEM. 2003.

11. Briones JC, Castañón JA, Díaz-de León M. Briones CG. Velocidad de flujo sanguíneo cerebral en la preeclampsia-eclampsia. Prog Obst Ginecol 2000;43:511-520.

12. Dekker GA, Van-Geijn HP. Endothelial dysfunction in preeclampsia. J Perinat Med 1996;24(2):99-117.

13. Velasco MV, Pozos CJL, Cardona PJA. Prevención y tratamiento de la preeclampsia-eclampsia. De la teoría a la práctica. Rev Med IMSS 2000;38(2):139-147.

14. García RH, García BC, Moreno AL. Evaluación de pruebas diagnósticas. Ch. 10. Epidemiología clínica, 2ª ed. McGraw-Hill. 1994:pp.160.

15. White W, Erickson MM, Stevens SC. Practical automation for the clinical laboratory. Hema-Tek silde stainer. 1970:476-487.

16. Vinatier D, Monnier JC. Artículo de revisión. Preeclampsia: fisiología y aspectos bioquímicos. Euro Gynecol Obstet 1995;61:85-97.

17. Pritchard JA, Meisman R Jr, Ratnoff OD, Vosburggh G. Intravascular hemolysis, thrombocytopenia and other hematologic abnormalities associated with severe toxemia of pregnancy. N Engl J Med 1954;250:89-98.

18. Espinosa-Morales ML, Díaz de León-Ponce M, Yáñez-Morales I, et al. Microangiopatía trombótica y hemólisis intravascular en la toxemia. Rev Med IMSS 1982;20(1):35-41.

19. Weinstein L. Syndrome of hemolytic, elevated liver enzymes, and low platelet count; a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 1982;142:159-167.

20. Suárez VR, Trilles JG, Miyahira JM. Urinary calcium in asymptomatic primigravidas who later developed preeclampsia. Gynecol Obstet Peru 1996;87(1):79-82.